Stay updated on Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Sign up to get notified when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A dedicated Locations section has been added with Zhejiang listed as the site. The page revision is updated to v3.3.3, and the old Zhejiang Locations entry plus the HHS Vulnerability Disclosure link have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T14:30:41.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page; this is a minor system update and does not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T19:06:49.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Removed the generic government funding/status notice from the page; core study details and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:11:17.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    No significant changes detected on the Study Details page between the two screenshots.
    Difference
    0.5%
    Check dated 2025-11-03T12:48:46.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    - Updated the page to v3.2.0 and added a government-operational status notice clarifying potential delays and open status of NIH Clinical Center. - Removed the previous version tag v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T17:30:22.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Page version updated from v3.0.2 to v3.1.0 with an added contact-like string (+86-571-87235147); no changes to core content, pricing, or availability inferred.
    Difference
    0.1%
    Check dated 2025-09-28T10:43:19.000Z thumbnail image

Stay in the know with updates to Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.